NCT06154044View on ClinicalTrials.gov

Cell Therapy and Myocardial Recovery in Heart Failure Patients Undergoing Left Ventricular Assist Device Support

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

May 31, 2025

Conditions
Heart FailureMechanical Circulatory Support
Interventions
BIOLOGICAL

CD34+ stem cell therapy

After 5-days GCSF stimulation all patients will undergo apheresis to obtain CD34+ cell which will subsequently be injected in the target coronary artery using microcatheter.

Trial Locations (1)

1000

RECRUITING

University Medical Center Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER